Insider · CIK 0001021015
Richard Douglas
Files at NVAX (NOVAVAX INC), MXCT (MAXCYTE, INC.), ALDX (Aldeyra Therapeutics, Inc.). First filing Aug 13, 2025, latest Aug 13, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MXCT: MAXCYTE, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | MAXCYTE, INC. | $111k 80,000 shares | +53% | +9% from low-73% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | MXCT MAXCYTE, INC. | POpen-market purchase Common Stock | +80,000 | $1.39 | $111k | 230,577 | Aug 13, 2025 |
| Jun 20, 2025 | NVAX NOVAVAX INC | AGrant or award Stock Option (Right to Buy)derivative | +28,326 | $6.42 | $182k | 28,326 | Jun 24, 2025 |
| Jun 20, 2025 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +18,884 | $0.00 | $0 | 18,884 | Jun 24, 2025 |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | AGrant or award Common Stock | +29,210 | $0.00 | $0 | 150,577 | Jun 23, 2025 |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | AGrant or award Stock Option (right to buy)derivative | +50,790 | $0.00 | $0 | 50,790 | Jun 23, 2025 |
| Jun 12, 2025 | NVAX NOVAVAX INC | MOption exercise Common Stock | +10,420 | $0.00 | $0 | 54,340 | Jun 13, 2025 |
| Jun 12, 2025 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -10,420 | $0.00 | $0 | 0 | Jun 13, 2025 |
| Jun 10, 2025 | ALDX Aldeyra Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +62,728 | $0.00 | $0 | 62,728 | Jun 12, 2025 |
| Jun 10, 2025 | ALDX Aldeyra Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +14,476 | $0.00 | $0 | 14,476 | Jun 12, 2025 |
| Jun 10, 2025 | ALDX Aldeyra Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,689 | $0.00 | $0 | 1,689 | Jun 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.